Ocular Therapeutix (OCUL) Stock Research

Ocular Therapeutix

· OCUL

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.728 B

-2.54%

Monday

Ocular Therapeutix falls -18.2%

OCUL

Sep 28, 12:00 PM

Ocular Therapeutix shares down 22% after 4D Molecular announces Phase 3 results

Sep 28, 11:19 AM

Ocular Therapeutix falls -18.1%

OCUL

Sep 28, 10:00 AM

Over a week ago

Ocular Therapeutix management to meet with Piper Sandler

OCUL

Sep 23, 4:44 PM

Ocular Therapeutix completes pre-NDA meeting with FDA for Axpaxli

OCUL

Sep 15, 7:13 AM

Clear Street sees less competition for Ocular after EyePoint miss

Aug 17, 4:20 PM

Ocular Therapeutix rises 10.4%

OCUL

Aug 17, 10:01 AM

Ocular Therapeutix reports Q2 EPS (35c), consensus (39c)

OCUL

Aug 3, 7:28 AM

Blair adds American Express, Oracle to Conviction List in monthly update

+39

Jul 1, 6:56 AM

Ocular Therapeutix price target raised by $4 at H.C. Wainwright, here's why

OCUL

Jun 18, 11:15 AM

Ocular Therapeutix price target raised by $6 at Baird, here's why

OCUL

Jun 18, 6:26 AM

Ocular Therapeutix trading resumes

OCUL

Jun 17, 9:15 AM

Ocular Therapeutix to resume trading at 9:15 am ET

OCUL

Jun 17, 8:53 AM

Ocular Therapeutix Investor Day to highlight FDA alignment on Axpaxli NDA

OCUL

Jun 17, 8:51 AM

Ocular Therapeutix trading halted, news pending

OCUL

Jun 17, 8:40 AM

Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)

OCUL

May 5, 7:49 AM

Ocular Therapeutix enrolls first patient in Axpali trial

OCUL

Apr 29, 7:25 AM

Ocular Therapeutix reports additional Axpaxli trial data

OCUL

Apr 13, 7:15 AM

Ocular Therapeutix price target raised by $3 at BofA, here's why

OCUL

Mar 3, 6:45 AM

Ocular Therapeutix price target raised by $7 at Clear Street, here's why

OCUL

Mar 2, 4:03 PM

What You Missed On Wall Street On Tuesday

+26

Feb 17, 4:31 PM

Charts